isoxazoles has been researched along with Carcinoma, Medullary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alhefdhi, A; Burke, JF; Chen, H; Kunnimalaiyaan, M; Redlich, A | 1 |
1 other study(ies) available for isoxazoles and Carcinoma, Medullary
| Article | Year |
|---|---|
Leflunomide suppresses growth in human medullary thyroid cancer cells.
Topics: Antineoplastic Agents; Antirheumatic Agents; Basic Helix-Loop-Helix Transcription Factors; Biomarkers; Carcinoma, Medullary; Carcinoma, Neuroendocrine; Cell Line, Tumor; Cell Proliferation; Chromogranin A; Dose-Response Relationship, Drug; Down-Regulation; Humans; Isoxazoles; Leflunomide; Thyroid Neoplasms | 2013 |